Wikipedia has been issued a notice by the ministry, questioning why it shouldn't be classified as a publisher with legal accountability in light of bias and inaccuracy accusations ...

The president of AstraZeneca’s China division has been placed under investigation by local police, as Beijing advances an anti-corruption crackdown in the healthcare sector. The British ...

AstraZeneca disclosed Wednesday that Leon Wang, a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese ...

A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt. The Health Secretary is ...

Before joining BeiGene, Yin spent 15 years with AstraZeneca, having served in various posts at the British drugmaker, including as head of its oncology business in China. Yin has been detained by ...

(IN BRIEF) AstraZeneca presented significant advancements in the prevention of infectious diseases at IDWeek 2024, showcasing its dedication to addressing respiratory infections caused by RSV, hMPV, ...

FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for self-administration by patients aged 18-49. FluMist is the first influenza ...

In an interview with China Daily, Sharon Barr, executive vice-president of biopharmaceuticals R&D at AstraZeneca, said the company's presence in Shanghai is absolutely critical to achieving its ...

The 2024 AstraZeneca prize in synthetic chemistry has been awarded to Ruth Webster, University of Cambridge, for her productive early career and innovative research, particularly in iron catalysis, ...

Steven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was ...

After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision.

"It's appalling the way AstraZeneca has been treated. I wouldn't blame them if they were thoroughly fed up and decided to bow out of the Covid vaccine business." That was the view from one of the ...